Table 1—

Characteristics of included trials

First author [Ref.]CountryIntervention group 1Intervention group 2Subjects nAge yrsMales %Mean FEV1Baseline 6MWD
Puhan 11SwitzerlandRespiratory rehabilitation (continuous exercise)Respiratory rehabilitation (interval exercise)9868.9±9.16734.3±8.4323±109
Goldstein 21CanadaRespiratory rehabilitationUsual care8966.0±7.24934.7±13.2366±99
Puhan 20SwitzerlandRespiratory rehabilitation7167.5±8.46645.1±15.4360±122
Mador 22USARespiratory rehabilitation2469.9±9.59244.3±17.1326±105
Mador 19USARespiratory rehabilitation (endurance exercise)Respiratory rehabilitation (strength exercise)2871.1±6.110042.0±14.7378±119
Mador 18USARespiratory rehabilitation (endurance and hyperpnea)Respiratory rehabilitation (endurance exercise)2970.3±7.410044.8±16.6435±98
Krauza 23USARespiratory rehabilitation (interval exercise)Respiratory rehabilitation (continuous exercise)4171.1±7.69843.1±13.1431±104
Mador, unpublished resultsUSARespiratory rehabilitation (endurance and upper arm exercise)Respiratory rehabilitation (endurance exercise)1773.9±7.010036.7±13.6383±79
Schünemann 33CanadaRespiratory rehabilitation6369.8±8.35438.9±14.5334±104
All46068.9±8.37139.2±14.1361±112
  • Data are presented as mean±sd, unless otherwise stated. FEV1: forced expiratory volume in one second; 6MWD: 6-min walk distance.